SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2018-04-02
Tx date 2018-03-28 		$COM
Cardiome Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+1,884 vol 		48,696
Filed 2018-04-02
Tx date 2018-03-28 		$COM
Cardiome Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-79,430
-47,000 vol
$1.69 each 		377,700
Filed 2018-04-02
Tx date 2018-03-28 		$COM
Cardiome Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$19,952
+11,806 vol
$1.69 each 		46,812
Filed 2018-04-02
Tx date 2018-03-28 		$COM
Cardiome Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Units Restricted Share Units
57 - Exercise of rights
-3,238 vol 		0
Filed 2018-04-02
Tx date 2018-03-28 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Units Restricted Share Units
57 - Exercise of rights
-13,102 vol 		0
Filed 2018-04-02
Tx date 2018-03-28 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+6,577 vol 		991,946
Filed 2018-04-02
Tx date 2018-03-28 		$COM
Cardiome Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Units Restricted Share Units
57 - Exercise of rights
-3,238 vol 		0
Filed 2018-04-02
Tx date 2018-03-28 		$COM
Cardiome Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-34,000
-20,000 vol
$1.70 each 		422,700
Filed 2018-04-02
Tx date 2018-03-28 		$COM
Cardiome Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$13,503
+7,943 vol
$1.70 each 		20,934
Filed 2018-04-02
Tx date 2018-03-28 		$COM
Cardiome Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+1,625 vol 		12,991
Filed 2018-04-02
Tx date 2018-03-28 		$COM
Cardiome Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-17,951.18
-7,943 vol
$2.26 each 		12,991
Filed 2018-03-27
Tx date 2018-03-23 		$COM
Cardiome Pharma Corp. 		Renz, Justin
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$286,500
+150,000 vol
$1.91 each 		425,000
Filed 2018-03-27
Tx date 2018-03-26 		$COM
Cardiome Pharma Corp. 		Renz, Justin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$19,844
+10,000 vol
$1.98 each 		30,000
Filed 2018-03-27
Tx date 2018-03-23 		$COM
Cardiome Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$238,750
+125,000 vol
$1.91 each 		424,700
Filed 2018-03-27
Tx date 2018-03-26 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-330,000
-200,000 vol
$1.65 each 		1,333,000
Filed 2018-03-27
Tx date 2018-03-23 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,120,500
+450,000 vol
$2.49 each 		1,533,000
Filed 2018-03-27
Tx date 2018-03-26 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$330,000
+200,000 vol
$1.65 each 		985,369
Filed 2018-03-27
Tx date 2018-03-23 		$COM
Cardiome Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$311,250
+125,000 vol
$2.49 each 		442,700
Filed 2018-03-27
Tx date 2018-03-23 		$COM
Cardiome Pharma Corp. 		Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$311,250
+125,000 vol
$2.49 each 		375,000
Filed 2017-10-16
Tx date 2017-10-10 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-5,120
-2,000 vol
$2.56 each
Filed 2017-10-16
Tx date 2017-10-10 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-43,081.64
-17,164 vol
$2.51 each
Filed 2017-10-16
Tx date 2017-10-10 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-43,081.64
-17,164 vol
$2.51 each
Filed 2017-10-16
Tx date 2017-10-10 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-2,016
-800 vol
$2.52 each
Filed 2017-10-16
Tx date 2017-10-10 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-2,016
-800 vol
$2.52 each
Filed 2017-10-16
Tx date 2017-10-10 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-5,120
-2,000 vol
$2.56 each
Filed 2017-10-02
Tx date 2017-09-27 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Holder: Christopher Michael Archibald (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-2,024
-800 vol
$2.53 each 		2,359
Filed 2017-10-02
Tx date 2017-09-27 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-768.00
-300 vol
$2.56 each 		19,964
Filed 2017-10-02
Tx date 2017-09-27 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-10,136.25
-3,975 vol
$2.55 each 		20,264
Filed 2017-10-02
Tx date 2017-09-27 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,255
-500 vol
$2.51 each 		24,239
Filed 2017-10-02
Tx date 2017-09-27 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-24,715
-9,886 vol
$2.50 each 		24,739
Filed 2017-10-02
Tx date 2017-09-27 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Holder: Christopher Michael Archibald (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-5,968.27
-2,359 vol
$2.53 each 		0
Filed 2017-10-02
Tx date 2017-09-27 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Holder: Christopher Michael Archibald (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,764
-700 vol
$2.52 each 		3,159
Filed 2017-10-02
Tx date 2017-09-27 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Holder: Christopher Michael Archibald (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-12,550
-5,000 vol
$2.51 each 		3,859
Filed 2017-10-02
Tx date 2017-09-27 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Holder: Christopher Michael Archibald (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-185.00
-74 vol
$2.50 each 		8,859
Filed 2017-10-02
Tx date 2017-09-27 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Holder: Christopher Michael Archibald (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,542
-600 vol
$2.57 each 		8,933
Filed 2017-10-02
Tx date 2017-09-27 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Holder: Christopher Michael Archibald (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-2,857.50
-1,125 vol
$2.54 each 		9,533
Filed 2017-08-28
Tx date 2017-08-25 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$33,938
+19,964 vol
$1.70 each 		34,625
Filed 2017-08-28
Tx date 2017-08-24 		$COM
Cardiome Pharma Corp. 		Renz, Justin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$22,622
+10,000 vol
$2.26 each 		20,000
Filed 2017-08-28
Tx date 2017-08-25 		$COM
Cardiome Pharma Corp. 		O'Shea, William James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$22,615
+10,000 vol
$2.26 each 		25,000
Filed 2017-08-28
Tx date 2017-08-25 		$COM
Cardiome Pharma Corp. 		Meyer, Robert James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,420
+2,000 vol
$2.21 each 		5,920
Filed 2017-08-28
Tx date 2017-08-25 		$COM
Cardiome Pharma Corp. 		Corrigan, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$22,000
+10,000 vol
$2.20 each 		10,000
Filed 2017-08-28
Tx date 2015-06-22 		$COM
Cardiome Pharma Corp. 		Corrigan, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-28
Tx date 2017-08-25 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-85,000
-50,000 vol
$1.70 each 		273,460
Filed 2017-08-25
Tx date 2017-08-25 		$COM
Cardiome Pharma Corp. 		Willms, Arthur Henry
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$27,599
+10,000 vol
$2.76 each 		18,000
Filed 2017-08-23
Tx date 2017-08-23 		$COM
Cardiome Pharma Corp. 		Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$22,950
+8,500 vol
$2.70 each 		14,500
Filed 2017-08-18
Tx date 2006-12-11 		$COM
Cardiome Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-18
Tx date 2017-08-14 		$COM
Cardiome Pharma Corp. 		O'Shea, William James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$68,600
+17,500 vol
$3.92 each 		68,974
Filed 2017-08-18
Tx date 2017-08-14 		$COM
Cardiome Pharma Corp. 		Meyer, Robert James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$49,000
+12,500 vol
$3.92 each 		35,100
Filed 2017-08-18
Tx date 2017-08-15 		$COM
Cardiome Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-37,400
-22,000 vol
$1.70 each 		53,000
Filed 2017-08-18
Tx date 2017-08-14 		$COM
Cardiome Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$63,125
+12,500 vol
$5.05 each 		75,000
Filed 2017-08-18
Tx date 2017-08-15 		$COM
Cardiome Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$24,554
+14,444 vol
$1.70 each 		14,444
Filed 2017-08-18
Tx date 2017-08-14 		$COM
Cardiome Pharma Corp. 		Corrigan, Mark
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$49,000
+12,500 vol
$3.92 each 		39,000
Filed 2017-06-26
Tx date 2017-06-23 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-490,000
-200,000 vol
$2.45 each 		1,083,000
Filed 2017-06-26
Tx date 2017-06-23 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$490,000
+200,000 vol
$2.45 each 		785,369
Filed 2017-05-19
Tx date 2017-05-16 		$COM
Cardiome Pharma Corp. 		Renz, Justin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-05-19
Tx date 2017-05-18 		$COM
Cardiome Pharma Corp. 		Renz, Justin
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$998,250
+275,000 vol
$3.63 each 		275,000
Filed 2017-05-19
Tx date 2017-05-16 		$COM
Cardiome Pharma Corp. 		Renz, Justin
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-05-19
Tx date 2017-05-17 		$COM
Cardiome Pharma Corp. 		Renz, Justin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$35,210
+10,000 vol
$3.52 each 		10,000
Filed 2017-04-07
Tx date 2017-03-28 		$COM
Cardiome Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+1,856 vol 		35,006
Filed 2017-04-07
Tx date 2017-03-28 		$COM
Cardiome Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Units Restricted Share Units
57 - Exercise of rights
-3,238 vol 		3,238
Filed 2017-04-04
Tx date 2017-03-31 		$COM
Cardiome Pharma Corp. 		Sachot, Hugues
5 - Senior Officer of Issuer
Direct Ownership
Units Restricted Share Units
56 - Grant of rights
+42,922 vol 		71,756
Filed 2017-04-04
Tx date 2017-03-31 		$COM
Cardiome Pharma Corp. 		Sachot, Hugues
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-378,750
-125,000 vol
$3.03 each 		97,700
Filed 2017-04-04
Tx date 2017-03-28 		$COM
Cardiome Pharma Corp. 		Sachot, Hugues
5 - Senior Officer of Issuer
Direct Ownership
Units Restricted Share Units
57 - Exercise of rights
-3,238 vol 		28,834
Filed 2017-03-31
Tx date 2017-03-28 		$COM
Cardiome Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Units Restricted Share Units
57 - Exercise of rights
-3,238 vol 		3,238
Filed 2017-03-31
Tx date 2017-03-28 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+1,693 vol 		14,661
Filed 2017-03-31
Tx date 2017-03-28 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Units Restricted Share Units
57 - Exercise of rights
-3,238 vol 		3,238
Filed 2017-03-31
Tx date 2017-03-28 		$COM
Cardiome Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+1,693 vol 		11,366
Filed 2017-03-31
Tx date 2017-03-28 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+6,852 vol 		594,704
Filed 2017-03-31
Tx date 2017-03-28 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Units Restricted Share Units
57 - Exercise of rights
-13,102 vol 		13,102
Filed 2017-03-30
Tx date 2017-03-29 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
-9,335 vol 		578,517
Filed 2017-03-30
Tx date 2013-11-20 		$COM
Cardiome Pharma Corp. 		Sachot, Hugues
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-03-30
Tx date 2017-03-29 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Cathryn Hunter (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift
+9,335 vol 		28,935
Filed 2017-03-27
Tx date 2017-03-22 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,604,000
+400,000 vol
$4.01 each 		1,283,000
Filed 2017-03-27
Tx date 2017-03-22 		$COM
Cardiome Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$501,250
+125,000 vol
$4.01 each 		317,700
Filed 2017-03-27
Tx date 2017-03-22 		$COM
Cardiome Pharma Corp. 		Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$501,250
+125,000 vol
$4.01 each 		250,000
Filed 2017-03-27
Tx date 2017-03-22 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$501,250
+125,000 vol
$4.01 each 		323,460
Filed 2017-03-27
Tx date 2017-03-22 		$COM
Cardiome Pharma Corp. 		Sachot, Hugues
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$378,750
+125,000 vol
$3.03 each 		222,700
Filed 2017-03-27
Tx date 2017-03-22 		$COM
Cardiome Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$378,750
+125,000 vol
$3.03 each 		299,700
Filed 2016-08-15
Tx date 2016-08-11 		$COM
Cardiome Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$50,125
+12,500 vol
$4.01 each 		62,500
Filed 2016-08-15
Tx date 2016-08-12 		$COM
Cardiome Pharma Corp. 		Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$24,900
+6,000 vol
$4.15 each 		6,000
Filed 2016-08-15
Tx date 2014-06-16 		$COM
Cardiome Pharma Corp. 		O'Shea, William James
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-08-15
Tx date 2016-08-11 		$COM
Cardiome Pharma Corp. 		Corrigan, Mark
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$38,500
+12,500 vol
$3.08 each 		26,500
Filed 2016-08-15
Tx date 2016-08-11 		$COM
Cardiome Pharma Corp. 		O'Shea, William James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$53,900
+17,500 vol
$3.08 each 		51,474
Filed 2016-08-15
Tx date 2016-08-11 		$COM
Cardiome Pharma Corp. 		O'Shea, William James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$47,599
+15,000 vol
$3.17 each 		15,000
Filed 2016-08-15
Tx date 2016-08-11 		$COM
Cardiome Pharma Corp. 		Meyer, Robert James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$38,500
+12,500 vol
$3.08 each 		22,600
Filed 2016-08-15
Tx date 2016-08-15 		$COM
Cardiome Pharma Corp. 		Meyer, Robert James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,700
+3,920 vol
$3.24 each 		3,920
Filed 2016-08-15
Tx date 2015-08-31 		$COM
Cardiome Pharma Corp. 		Meyer, Robert James
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-08-15
Tx date 2016-08-12 		$COM
Cardiome Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$99,186
+31,093 vol
$3.19 each 		33,150
Filed 2016-08-15
Tx date 2016-08-12 		$COM
Cardiome Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$15,120
+4,800 vol
$3.15 each 		9,673
Filed 2016-08-15
Tx date 2016-08-12 		$COM
Cardiome Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,440
+2,400 vol
$3.10 each 		4,873
Filed 2016-08-12
Tx date 2016-08-11 		$COM
Cardiome Pharma Corp. 		Willms, Arthur Henry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$50,125
+12,500 vol
$4.01 each 		26,500
Filed 2016-08-12
Tx date 2016-08-11 		$COM
Cardiome Pharma Corp. 		Willms, Arthur Henry
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$20,650
+5,000 vol
$4.13 each 		8,000
Filed 2016-08-11
Tx date 2007-06-11 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Cathryn Hunter (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-08-11
Tx date 2016-08-11 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Cathryn Hunter (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$80,556
+19,600 vol
$4.11 each 		19,600
Filed 2016-08-11
Tx date 2016-08-11 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$86,310
+21,000 vol
$4.11 each 		587,852
Filed 2016-06-30
Tx date 2016-06-27 		$COM
Cardiome Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Units Restricted Share Units
57 - Exercise of rights
-3,238 vol 		6,476
Filed 2016-06-30
Tx date 2016-06-21 		$COM
Cardiome Pharma Corp. 		Sachot, Hugues
5 - Senior Officer of Issuer
Direct Ownership
Units Restricted Share Units
56 - Grant of rights
+25,596 vol 		32,072
Filed 2016-06-30
Tx date 2016-03-26 		$COM
Cardiome Pharma Corp. 		Sachot, Hugues
5 - Senior Officer of Issuer
Direct Ownership
Units Restricted Share Units
57 - Exercise of rights
-3,238 vol 		6,476
Filed 2016-06-30
Tx date 2016-06-27 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Units Restricted Share Units
57 - Exercise of rights
-13,102 vol 		26,204
Filed 2016-06-30
Tx date 2016-06-27 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+6,852 vol 		566,852
Filed 2016-06-30
Tx date 2016-06-27 		$COM
Cardiome Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+1,693 vol 		2,473
Filed 2016-06-30
Tx date 2016-06-27 		$COM
Cardiome Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Units Restricted Share Units
57 - Exercise of rights
-3,238 vol 		6,476
Filed 2016-06-30
Tx date 2016-06-27 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Units Restricted Share Units
57 - Exercise of rights
-3,238 vol 		6,476
Filed 2016-06-30
Tx date 2016-06-27 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+1,693 vol 		12,968
Filed 2016-06-30
Tx date 2016-06-27 		$COM
Cardiome Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+2,057 vol 		2,057
Filed 2016-06-30
Tx date 2012-11-01 		$COM
Cardiome Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-24
Tx date 2016-06-21 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$461,250
+75,000 vol
$6.15 each 		198,460
Filed 2016-06-24
Tx date 2016-06-21 		$COM
Cardiome Pharma Corp. 		McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$363,000
+75,000 vol
$4.84 each 		174,700
Filed 2016-06-24
Tx date 2016-06-21 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,537,500
+250,000 vol
$6.15 each 		883,000
Filed 2016-06-24
Tx date 2016-06-21 		$COM
Cardiome Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$461,250
+75,000 vol
$6.15 each 		192,700
Filed 2016-06-24
Tx date 2016-06-21 		$COM
Cardiome Pharma Corp. 		Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$461,250
+75,000 vol
$6.15 each 		125,000
Filed 2016-06-22
Tx date 2015-06-22 		$COM
Cardiome Pharma Corp. 		Willms, Arthur Henry
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-22
Tx date 2016-06-22 		$COM
Cardiome Pharma Corp. 		Willms, Arthur Henry
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$18,930
+3,000 vol
$6.31 each 		3,000
Filed 2016-03-24
Tx date 2016-03-24 		$COM
Cardiome Pharma Corp. 		Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-123,500
-5,000 vol
$24.70 each 		117,700
Filed 2015-09-30
Tx date 2015-08-31 		$COM
Cardiome Pharma Corp. 		Meyer, Robert James
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-09-30
Tx date 2015-09-25 		$COM
Cardiome Pharma Corp. 		Meyer, Robert James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$98,374
+10,100 vol
$9.74 each 		10,100
Filed 2015-08-12
Tx date 2015-06-22 		$COM
Cardiome Pharma Corp. 		Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		50,000
Filed 2015-08-12
Tx date 2015-06-22 		$COM
Cardiome Pharma Corp. 		Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-07-14
Tx date 2015-06-22 		$COM
Cardiome Pharma Corp. 		O'Shea, William James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$46,640
+4,000 vol
$11.66 each 		33,974
Filed 2015-06-29
Tx date 2015-06-22 		$COM
Cardiome Pharma Corp. 		Willms, Arthur Henry
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		14,000
Filed 2015-06-29
Tx date 2015-06-22 		$COM
Cardiome Pharma Corp. 		Willms, Arthur Henry
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-06-26
Tx date 2015-06-22 		$COM
Cardiome Pharma Corp. 		Corrigan, Mark
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-06-26
Tx date 2015-06-22 		$COM
Cardiome Pharma Corp. 		Shlevin, Harold
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$116,600
+10,000 vol
$11.66 each 		50,000
Filed 2015-06-26
Tx date 2015-06-22 		$COM
Cardiome Pharma Corp. 		O'Shea, William James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$116,600
+10,000 vol
$11.66 each 		29,974
Filed 2015-06-26
Tx date 2015-06-22 		$COM
Cardiome Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$116,600
+10,000 vol
$11.66 each 		50,000
Filed 2015-06-26
Tx date 2015-06-22 		$COM
Cardiome Pharma Corp. 		Corrigan, Mark
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$163,240
+14,000 vol
$11.66 each 		14,000
Filed 2015-06-04
Tx date 2015-06-02 		$COM
Cardiome Pharma Corp. 		Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-8,640
-200 vol
$43.20 each 		123,460
Filed 2015-05-28
Tx date 2015-05-25 		$COM
Cardiome Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-124,200
-3,000 vol
$41.40 each 		40,000
Filed 2015-05-28
Tx date 2015-05-25 		$COM
Cardiome Pharma Corp. 		Shlevin, Harold
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-124,200
-3,000 vol
$41.40 each 		40,000
Filed 2015-05-28
Tx date 2015-05-25 		$COM
Cardiome Pharma Corp. 		Roberts, Peter W
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-124,200
-3,000 vol
$41.40 each 		40,000
Filed 2015-05-28
Tx date 2015-05-25 		$COM
Cardiome Pharma Corp. 		Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-124,200
-3,000 vol
$41.40 each 		633,000
Filed 2015-05-15
Tx date 2015-05-14 		$COM
Cardiome Pharma Corp. 		O'Shea, William James
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-82,513.98
-10,026 vol
$8.23 each 		19,974